Autres langues Verona Pharma plc

Actions

VRNA

US9250501064

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 24/04/2024			Varia. 5j.	Varia. 1 janv.
15,24 ^USD	-2,25 %		-5,93 %	-23,34 %

22/04	Les actions européennes négociées aux États-Unis sous forme de certificats de dépôt américains rebondissent lundi matin	MT
16/04	Les actions européennes négociées aux États-Unis en tant qu'American Depositary Receipts sont en baisse dans les échanges de mardi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	22/04
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	16/04
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower	05/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	04/04
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	26/03
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading	25/03
Verona Pharma : Notice and Proxy Statement AGM 2024	21/03
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	21/03
Verona Pharma : Notice and Proxy Statement AGM 2024	20/03
Verona Pharma : Form of Proxy Card (Ordinary Shareholders)	20/03
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	14/03
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	13/03
Andrew Fisher Joins Verona Pharma as General Counsel	04/03
Verona Pharma plc Announces Management Changes	04/03
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	01/03
Verona Pharma Shares Rise After Narrower-Than-Expected Q4 Loss	29/02
Verona Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29/02
Verona Pharma plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading	27/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Verona Pharma plc

Actions

VRNA

US9250501064

Autres langues

Filtres